EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of vaccines at the time of COVID-19

Jeffrey Almond, Jörg Hacker, Colin Harwood, Mariagrazia Pizza, Rino Rappuoli, Eliora Z Ron iD, Philippe Sansonetti, Samantha Vanderslott, Lothar H Wieler

microLife · 2020

DOI: 10.1093/femsml/uqaa003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift microLife, 2020. Verfasst von Jeffrey Almond und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.

Schlagwörter

Stichwörter der Autor:innen

COVID-19pandemicspathogensvaccinationvaccinesvaccinology

Autor:innen und Institutionen

  • The Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
  • German National Academy of Science Leopoldina, Jägerberg 1, 06108 Halle, Germany.
  • Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne NE2 4AX, UK.
  • GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy.
  • The Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, PO Box 39040, Tel Aviv 6997801, Israel.
  • Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France.

ORCID-Profile: Eliora Z Ron

Zitieren

APA

Almond, J., Hacker, J., Harwood, C., Pizza, M., Rappuoli, R., Ron, E. Z., Sansonetti, P., Vanderslott, S., & Wieler, L. H. (2020). Development of vaccines at the time of COVID-19. microLife. https://doi.org/10.1093/femsml/uqaa003

Vancouver

Almond J, Hacker J, Harwood C, Pizza M, Rappuoli R, Ron EZ, et al. Development of vaccines at the time of COVID-19. microLife. 2020. doi:10.1093/femsml/uqaa003

BibTeX
@article{Almond2020,
  author = {Almond, Jeffrey and Hacker, Jörg and Harwood, Colin and Pizza, Mariagrazia and Rappuoli, Rino and Ron, Eliora Z and Sansonetti, Philippe and Vanderslott, Samantha and Wieler, Lothar H},
  title = {Development of vaccines at the time of COVID-19},
  journal = {microLife},
  year = {2020},
  doi = {10.1093/femsml/uqaa003}
}
Kostenlos starten →